APB-BS2

N/A

Report date: 2024/11/21 15:14:57

Base Information

Drug NameAPB-BS2

Drug Alias NameAPB-BS2

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionCoagulation factor VIII stimulants

TargetsCoagulation factor VIII

Therapy Area/IndicationsTriple Negative Breast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAprilBio Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesAprilBio Co Ltd

Inactive CompaniesN/A

Active IndicationsTriple Negative Breast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A